We are live on ! Find out more
VCM

Versant Capital Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 34.21%
This Fund
S&P 500
This Quarter Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
Cap. Flow
+$19.1M
Cap. Flow %
1.71%
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.02%
2 Technology 19.06%
3 Financials 7.05%
4 Industrials 6.05%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCUS icon
2201
Arcus Biosciences
RCUS
$3.25B
$11K ﹤0.01%
358
LDOS icon
2202
Leidos
LDOS
$16.4B
$11K ﹤0.01%
107
-1,715
-94% -$228K
BEPC icon
2203
Brookfield Renewable
BEPC
$5.54B
$10.9K ﹤0.01%
294
-45
-13% -$1.74K
ARTY
2204
iShares Future AI & Tech ETF
ARTY
$4.01B
$10.9K ﹤0.01%
143
BUR icon
2205
Burford Capital
BUR
$876M
$10.8K ﹤0.01%
2,624
+2,072
+375% +$9.47K
IUSB icon
2206
iShares Core Universal USD Bond ETF
IUSB
$43.6B
$10.8K ﹤0.01%
233
SHBI icon
2207
Shore Bancshares
SHBI
$773M
$10.7K ﹤0.01%
466
LCII icon
2208
LCI Industries
LCII
$2.1B
$10.7K ﹤0.01%
101
-321
-76% -$35.3K
CMP icon
2209
Compass Minerals
CMP
$1B
$10.7K ﹤0.01%
343
+28
+9% +$792
FISI icon
2210
Financial Institutions
FISI
$802M
$10.7K ﹤0.01%
274
KNSA icon
2211
Kiniksa Pharmaceuticals
KNSA
$6.19B
$10.6K ﹤0.01%
166
ADPT icon
2212
Adaptive Biotechnologies
ADPT
$4.56B
$10.6K ﹤0.01%
494
CONY icon
2213
YieldMax COIN Option Income Strategy ETF
CONY
$338M
$10.6K ﹤0.01%
560
+55
+11% +$1.36K
NCLH icon
2214
Norwegian Cruise Line
NCLH
$6.61B
$10.5K ﹤0.01%
+499
New +$9.31K
RLAY icon
2215
Relay Therapeutics
RLAY
$4.21B
$10.5K ﹤0.01%
559
+66
+13% +$958
MAX icon
2216
MediaAlpha
MAX
$560M
$10.4K ﹤0.01%
829
-170
-17% -$1.6K
RIGL icon
2217
Rigel Pharmaceuticals
RIGL
$856M
$10.4K ﹤0.01%
266
+29
+12% +$894
AGI icon
2218
Alamos Gold
AGI
$15B
$10.4K ﹤0.01%
343
-293
-46% -$11.9K
IPI icon
2219
Intrepid Potash
IPI
$531M
$10.4K ﹤0.01%
317
+97
+44% +$3.69K
DNOW icon
2220
DNOW Inc
DNOW
$2.88B
$10.4K ﹤0.01%
800
NUVL
2221
DELISTED
Nuvalent
NUVL
$10.4K ﹤0.01%
84
GSLC icon
2222
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.1B
$10.4K ﹤0.01%
73
+41
+128% +$5.67K
ESRT icon
2223
Empire State Realty Trust
ESRT
$720M
$10.4K ﹤0.01%
1,914
+905
+90% +$4.92K
JMSB icon
2224
John Marshall Bancorp
JMSB
$326M
$10.4K ﹤0.01%
475
RGP icon
2225
Resources Connection
RGP
$137M
$10.3K ﹤0.01%
+2,426
New +$10.2K

Similar funds

Versant Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Financials.

  • Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
  • Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
  • Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
  • Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
  • Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
  • Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
  • Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.